Why PCOS Was Renamed PMOS: How It Changes Your Diagnosis and Treatment

If you have been diagnosed with PCOS, or suspect you might have it, you may have recently come across a name you have never heard before — PMOS.
It is not a new condition or new diagnosis. It’s the same condition you already know but now with a new name that finally tells the truth about what it actually is.

On May 12, 2026, The Lancet published a landmark global consensus officially renaming Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The change came after 14 years of research, 56 international organisations, and input from over 22,000 patients and health professionals worldwide.

Here is everything you need to know.

What Was PCOS?

If you are a woman in your reproductive years, chances are you have heard of PCOS.
Polycystic Ovary Syndrome (PCOS) has been one of the most common hormonal conditions affecting women worldwide, with an estimated 170 million women living with it globally according to the World Health Organization (WHO). In India alone, studies suggest between 9 and 22 percent of women experience it.

For decades, women were told they had “cysts on their ovaries.”
But here is the thing, most of them did not.
What doctors were seeing on ultrasound were small immature follicles, not true cysts.
The name was misleading from the start, and that misleading name had real consequences.
Women were misdiagnosed, underdiagnosed, and often left confused about what was actually happening in their bodies.

So What Is PMOS?

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. Let us break this down in simple language:

Polyendocrine — It means multiple hormones are involved, not just one. This is not purely an ovarian problem. It involves insulin, androgens, and other hormonal systems working together.
Metabolic — This condition deeply affects how your body processes energy, blood sugar, and weight. Insulin resistance is central to PMOS, even in women who are not overweight.
Ovarian — The ovaries are still involved and still central to understanding the condition. That part has not changed.
Syndrome — Correctly reflects that this is a cluster of features, not a single cause disease.

Who Changed It and When?

The rename did not happen overnight. It took 14 years in the making.

The process was led by Professor Helena Teede from Monash University in Australia, alongside the International Androgen Excess and PCOS Society. It involved 56 leading academic, clinical, and patient organisations across the world, and gathered over 22,000 survey responses from patients and health professionals in every region of the globe.

The final consensus was published in The Lancet on May 12, 2026, and presented at the European Congress of Endocrinology in Prague. It was described as the most robust disease renaming process in medical history.

This was not a decision made in a boardroom. It was driven by patients who had spent years feeling confused, dismissed, and misunderstood by a name that did not reflect their reality.

Why Did They Rename PCOS to PMOS?

Furthermore, the old name was doing real harm.

The word “polycystic” implied that ovarian cysts were the defining feature of the condition. But a significant number of women diagnosed with PCOS never had cysts at all. This caused missed diagnoses, delayed treatment, and unnecessary anxiety for millions of women who were told something was wrong with their ovaries when the real issue was far more complex.

Additionally, the name framed PCOS as purely a reproductive or gynaecological condition. This meant its metabolic effects, including insulin resistance, elevated risk of type 2 diabetes, cardiovascular disease, and high blood pressure, were consistently overlooked. Cardiologists were not in the room because the name suggested it was purely a gynaecology problem.

On top of that, the condition carried stigma around weight and fertility that the old name reinforced. The new name PMOS removes the focus from cysts and places it where it belongs, on the full hormonal and metabolic complexity of the condition.

Is It PCOS or PMOS? Which Should You Use Now?

Both terms will coexist for the next few years and that is completely normal.

Full implementation of PMOS across global medical guidelines is expected by 2028. Until then, your doctor may still use PCOS in your medical records, prescriptions, and referral letters as transition takes time across healthcare systems worldwide.

If you ever search for information online, you will still find far more results under PCOS than PMOS for now.
Both searches will lead you to the same condition.
Think of it the way a city changes its name. The place is the same, the people are the same, only the label on the map has changed.

For now, use whichever term your doctor uses. By 2028, PMOS will be the standard across guidelines in 195 countries.

PCOD vs PCOS vs PMOS: Clearing the Confusion

If you are someone who has likely heard all three terms and wondered what the difference is, you are not alone. This is one of the most searched questions among all in the health forums.

Here is a simple breakdown:

PCOD stands for Polycystic Ovarian Disease. It is an older, informal term still widely used in India. It generally refers to a milder presentation where the ovaries produce excess immature eggs. Many doctors in India use PCOD and PCOS interchangeably, though technically they are not identical. If you want to understand the differences between PCOD and PCOS in detail, we have covered that thoroughly here.

PCOS stands for Polycystic Ovary Syndrome. This is the formal clinical term that has been used globally for decades and is now being phased out.

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. This is the new official global term published in The Lancet in May 2026, replacing PCOS entirely.

PCOD or PCOS were the global clinical term. PMOS is the new one that more accurately describes the condition. If your doctor has diagnosed you with PCOD or PCOS, your diagnosis is still valid. Nothing about your health status has changed.

What Are the Symptoms? Has Anything Changed?

This is the question most women are asking right now and the answer is reassuring.

The symptoms of PMOS are exactly the same as what was previously called PCOS. The rename reflects a better understanding of the condition, not a change in how it presents or how it affects your body.

Symptoms can include:

Irregular or absent periods, excess androgen levels which may show up as acne, unwanted facial or body hair, or hair thinning on the scalp, difficulty managing weight, insulin resistance even in women who are not overweight, fertility challenges, fatigue, mood changes, anxiety, and depression.

Importantly, one shift the new name brings is that it draws more attention to the metabolic and mental health dimensions of the condition. Under the old PCOS framing, these aspects were often underplayed. With PMOS, doctors are being directed to screen more thoroughly for insulin resistance, cardiovascular risk, and mental health alongside reproductive symptoms.

So while the symptoms list has not changed, the expectation is that doctors will now look more broadly and more carefully at the whole picture.

What Should You Do If You Are Already Diagnosed?

If you have been diagnosed with PCOS or PCOD, here is the honest, practical answer: nothing urgent needs to change right now.

Your diagnosis is valid and treatment plan remains the same. Medications, lifestyle recommendations, and follow up care are all still appropriate.

However, what you can do at your next doctor’s appointment is ask about PMOS. Ask whether your metabolic health has been assessed, including your insulin resistance and cardiovascular risk. Ask whether your mental health has been considered as part of your care. These are questions the new name is specifically designed to prompt.

If you have been struggling to get a diagnosis despite having symptoms, the rename may work in your favour. As guidelines update toward PMOS, the clinical criteria are expected to broaden, which means fewer women will fall through the diagnostic gaps they have for decades.

Conclusion

For millions of women around the world, a PCOS diagnosis came with confusion, frustration, and often years of feeling dismissed.
A name that pointed at cysts that were not really cysts, in organs that were only part of the story, was never going to serve them well.

PMOS is not just a new acronym.
It is an acknowledgment that this condition is complex, whole-body, and deserving of serious medical attention across hormones, metabolism, mental health, and reproductive health together.

The label has changed.
Your strength in managing this condition has not.

If you found this article helpful, share it with someone who needs to know.
And if you have questions about your own diagnosis or symptoms, speak with your doctor about what PMOS means for your specific care.

SOURCES

1. Teede HJ et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published May 12, 2026. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext
2. World Health Organization. Polycystic ovary syndrome fact sheet. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
3. Apollo Hospitals India. PCOD: Causes, Symptoms, Diagnosis and Treatment. https://www.apollohospitals.com/diseases-and-conditions/pcod-polycystic-ovarian-disease
4. MedBound Times. PCOS name change to PMOS by Lancet. https://www.medboundtimes.com/medicine/pcos-name-change-to-pmos-by-lancet

Image Disclaimer: The image above are AI-generated and used for illustrative purposes only. It does not depict any real person, place, or event.